Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug for preventing and treating alcoholic liver disease

A technology of alcoholic liver disease and medicament, which is applied in the fields of acute alcoholic liver injury and alcoholic liver fibrosis, prevention and treatment of alcoholic liver disease, and can solve the problems of curative effect blocking progress of alcoholic liver disease, so as to achieve prevention and treatment Alcoholic liver fibrosis symptoms, simple raw material components, and the effect of improving liver cell swelling and fatty degeneration

Active Publication Date: 2018-03-13
THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIV
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, so far there is no drug that has a particularly good curative effect and blocks the progression of alcoholic liver disease

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug for preventing and treating alcoholic liver disease
  • Drug for preventing and treating alcoholic liver disease
  • Drug for preventing and treating alcoholic liver disease

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0056] Another object of the present invention is to provide a preparation method of a medicament for preventing and treating alcoholic liver disease, the preparation is a liquid medicament, and the preparation method comprises the following steps:

[0057] Step (1), preparing the Lactobacillus rhamnosus supernatant;

[0058] In step (2), vitamin E is added to the supernatant of Lactobacillus rhamnosus, preferably sodium tanshinone IIA sulfonate is also added.

[0059] In step (1), preparing the Lactobacillus rhamnosus supernatant comprises the following steps:

[0060] Step (1-1) activation: take 3% inoculum of Lactobacillus rhamnosus and inoculate it into MRS liquid medium (weigh 14.4g MRS broth powder and dissolve it in 300ml distilled water, store at 4°C after autoclaving), 37 Cultivate with shaking at ℃ for 20-30 hours, so that the strains in the liquid medium reach the set concentration;

[0061] Step (1-2) purification: take the bacterial solution and inoculate it in ...

Embodiment 1

[0074] The composition of the prescription is as follows: 1 mL of Lactobacillus rhamnosus supernatant and 100 mg of vitamin E.

[0075] Adopt following preparation method to obtain liquid medicament:

[0076] Step (1), preparing the Lactobacillus rhamnosus supernatant;

[0077]Activation: Take 3% inoculum of Lactobacillus rhamnosus and inoculate it into 5mL MRS liquid medium (weigh 14.4g MRS broth powder and dissolve it in 300ml distilled water, store at 4°C after autoclaving), shake and culture at 37°C for 24 hours , so that the strains in the liquid medium reach A600 of 1.380-1.400;

[0078] Purification: Inoculate 150 μL of bacterial liquid into MRS solid medium and incubate at 37°C for 24 hours;

[0079] Proliferation: Inoculate pale white circular flat single colonies with a diameter of 1.8-2mm into 4-6mL MRS liquid culture medium, culture at 37°C for 24 hours, and screen for highly active bacteria;

[0080] Extraction: Centrifuge the highly active bacterial solution a...

Embodiment 2

[0083] The composition of the prescription is as follows: 1 mL of supernatant of Lactobacillus rhamnosus, 100 mg of vitamin E and 50 mg of sodium tanshinone ⅡA sulfonate.

[0084] Adopt following preparation method to obtain liquid medicament:

[0085] Step (1), prepare Lactobacillus rhamnosus supernatant, method is the same as embodiment 1;

[0086] In step (2), 100 mg of vitamin E and 50 mg of sodium tanshinone IIA sulfonate are added to 1 mL of the supernatant of Lactobacillus rhamnosus to obtain a liquid medicine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
absorbanceaaaaaaaaaa
Login to View More

Abstract

The invention discloses a drug for preventing and treating the alcoholic liver disease. Active ingredients of the drug comprise lactobacillus rhamnosus liquid supernatant and vitamin E, and preferablytanshinone IIA sodium sulfonate is added. Based on the modern pathological study, the drug is combined with the theory of traditional Chinese medicine; according to the curative effect, the drug hasthe effects of restoring intestinal barrier damages caused by alcohol, improving oxidization resistance of livers, improving cellular swelling and fatty degeneration of the livers, relieving fibrous septum, and the like, and has obvious prevention and treatment effect on acute alcoholic liver injury and alcohol hepatic fibrosis.

Description

technical field [0001] The invention relates to the field of compound medicaments, in particular to medicaments for preventing and treating alcoholic liver disease, especially acute alcoholic liver injury and alcoholic liver fibrosis. Background technique [0002] Alcoholic liver disease refers to a series of alcohol-related liver diseases caused by prolonged or excessive alcohol intake, such as alcoholic fatty liver, alcoholic hepatitis, alcoholic liver fibrosis, alcoholic cirrhosis, and alcoholic liver cancer. The latest epidemiological survey found that with economic development and changes in lifestyle, alcohol dependence and alcohol abuse have become increasingly serious public health problems in today's world, and alcohol has become the leading cause of liver damage after hepatitis virus worldwide. the second leading cause of disease. Studies have shown that more than 90% of alcoholics suffer from fatty liver, of which 10% to 35% can develop into alcoholic hepatitis, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/747A61P1/16C12P1/04C12R1/225A61K31/58A61K31/355
CPCA61K31/355A61K31/58A61K35/747C12P1/04C12N1/205C12R2001/225A61K2300/00
Inventor 陈永平陈达之萧云蕾许烂漫李骥卢明芹金晓芝
Owner THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com